EPS for Bio-Path Holdings, Inc. (BPTH) Expected At $-0.60

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Logo

Analysts expect Bio-Path Holdings, Inc. (NASDAQ:BPTH) to report $-0.60 EPS on August, 21.They anticipate $2.40 EPS change or 80.00 % from last quarter’s $-3 EPS. After having $-0.89 EPS previously, Bio-Path Holdings, Inc.’s analysts see -32.58 % EPS growth. The stock increased 1.84% or $0.22 during the last trading session, reaching $12.18. About 114,134 shares traded. Bio-Path Holdings, Inc. (NASDAQ:BPTH) has declined 50.86% since August 16, 2018 and is downtrending. It has underperformed by 50.86% the S&P500.

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused antisense drug development firm in the United States. The company has market cap of $34.49 million. The firm develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid backbone modification intended to protect the DNA from destruction. It currently has negative earnings. The Company’s lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia and chronic myelogenous leukemia; and in preclinical studies for solid tumors, including breast cancer and ovarian cancer.

More notable recent Bio-Path Holdings, Inc. (NASDAQ:BPTH) news were published by: Seekingalpha.com which released: “22nd Century Group and Tenax Therapeutics among healthcare gainers; Ligand Pharmaceuticals and Endologix among the losers – Seeking Alpha” on March 06, 2019, also Seekingalpha.com with their article: “Bio-Path up 24% premarket – Seeking Alpha” published on January 22, 2019, Benzinga.com published: “60 Biggest Movers From Yesterday – Benzinga” on July 18, 2019. More interesting news about Bio-Path Holdings, Inc. (NASDAQ:BPTH) were released by: Globenewswire.com and their article: “Bio-Path Holdings Announces 1-for-10 Reverse Stock Split – GlobeNewswire” published on February 09, 2018 as well as Globenewswire.com‘s news article titled: “Bio-Path Holdings, Inc. Announces Closing of $1.5 Million Registered Direct Offering – GlobeNewswire” with publication date: September 25, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.